Clinical Trials Logo

Clinical Trial Summary

The investigators aim to demonstrate the efficacy and safety of subconjunctival injection of Avastin as an adjunctive therapy for Ahmed valve glaucoma implant in patients with refractory glaucoma.


Clinical Trial Description

Several studies have revealed evidences on the substantial role of Vascular endothelial growth factor-A (VEGF-A) in enhancing neovascularization processes. Some studies have shown the efficacy of intravitreal Avastin in reducing level of VEGF-A to improve NVG. On the other hand, recent pathological studies demonstrated that neutralization of VEGF reduced vascularity and decreased scar formation during wound healing, showing that VEGF strongly influence scar tissue formation. This may reduce the formation of encapsulated cyst after glaucoma surgeries and thus might improve the surgical success rate. The effect of subconjunctival bevacizumab as an adjunctive therapy in filtering glaucoma surgeries has been recently illustrated.

We aim to demonstrate the efficacy and safety of subconjunctival injection of Avastin as an adjunctive therapy for Ahmed valve glaucoma implant in patients with refractory glaucoma. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01128699
Study type Interventional
Source Vanak Eye Surgery Center
Contact Nariman Nassiri, MD
Phone (+98) 21 8877 4143
Email drnassirin@sbmu.ac.ir
Status Recruiting
Phase Phase 3
Start date May 2010
Completion date July 2011

See also
  Status Clinical Trial Phase
Completed NCT05521334 - MicroPulse Transscleral Laser Cyclophotocoagulation With the Zig Zag Mode in Glaucoma. N/A
Recruiting NCT00349414 - Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma Phase 1/Phase 2
Recruiting NCT04921098 - CPC in Adult Refractory Glaucoma N/A
Completed NCT01404364 - Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye N/A
Completed NCT00971061 - Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma Phase 3
Not yet recruiting NCT05230355 - Comparison Between Two Techniques of Subthreshold Diode Laser Cyclophotocoagulation in Refractory Glaucoma N/A
Completed NCT04303897 - Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma
Recruiting NCT00893490 - Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma Phase 1